The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Early determination of treatment sensitivity in HIV-related Hodgkin lymphoma by FDG-PET/CT after two cycles of ABVD chemotherapy:  A European Cooperative Study Group on AIDS and Tumors (GECAT) study.
Nicolas Mounier
No relevant relationships to disclose
Mark Bower
No relevant relationships to disclose
Michele Spina
No relevant relationships to disclose
Caroline Besson
No relevant relationships to disclose
Clara Schiantarelli
No relevant relationships to disclose
Alessandro Re
No relevant relationships to disclose
Fabrice Bonnet
No relevant relationships to disclose
Marcus Hentrich
No relevant relationships to disclose
Christoph Wyen
No relevant relationships to disclose
Eric Van Den Neste
No relevant relationships to disclose
Irene Vandoni
No relevant relationships to disclose
Umberto Tirelli
No relevant relationships to disclose
Eugenio Borsatti
No relevant relationships to disclose